Lizza Lebron‐Zapata

Author

Lizza Lebron‐Zapata

Memorial Sloan Kettering Cancer Center

Also Known As

L Lebron-Zapata, Lizza Lebron-Zapata, Lizza Lebron‐Zapata

Publications

345

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cedars-Sinai Medical Center Massachusetts General Hospital

About

Lizza Lebron‐Zapata is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, breast cancer, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	114
2	Immunology	2	2	32
3	Health Sciences	1	1	21
4	Public Health	1	1	43
5	Gender Studies	1	1	43

Lizza Lebron‐Zapata

Publications

302

Citations

H-Index

Page 1

	Year	Citations
A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple‐negative breast cancer Alice Y. Ho, Christopher A. Barker, Brittany Arnold, Cancer	2019	188
Breast cancer screening in transgender patients: findings from the 2014 BRFSS survey Anand K. Narayan, Lizza Lebron‐Zapata, Elizabeth A. Morris Breast Cancer Research and Treatment Transgender MedicineTransgender PatientsBreast OncologyCancer EpidemiologyCancer Screening	2017	43
Breast Imaging for Transgender Individuals: Assessment of Current Practice and Needs Emily B. Sonnenblick, Lizza Lebron‐Zapata, Roger Yang, Journal of the American College of Radiology Transgender MedicineMedical ImagingTransgender IndividualsMedicineGynecology	2021	21
A single-arm, phase II study assessing the efficacy of pembrolizumab (pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC). Heather L. McArthur, Christopher A. Barker, Ayca Gucalp, Journal of Clinical Oncology Breast OncologyImmunologyPhase Ii StudyImmunotherapeuticsImmunotherapy	2018	19
Does Breast Density Increase the Risk of Re-excision for Women with Breast Cancer Having Breast-Conservation Therapy? Siún Walsh, Sandra Brennan, Emily C. Zabor, Annals of Surgical Oncology Surgical OncologyBreast OncologyMedicineCancer ManagementBrachytherapy	2019	18
A phase II, single arm study assessing the efficacy of pembrolizumab (Pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC). Heather L. McArthur, Christopher A. Barker, Ayca Gucalp, Journal of Clinical Oncology Breast OncologyCancer ManagementImmunologySingle Arm StudyPathology	2018	13

Page 1